## XYL: Xylem Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 -1.2% below STRENGTH zone (4.0-10.0%); PEG 2.14 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($132.59)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Neuberger Berman Group LLC Sells 10,626 Shares of Xylem Inc. $XYL**
- Source: MarketBeat | 20251214T160810 | Somewhat-Bullish | Relevance: 100%
- Neuberger Berman Group LLC decreased its stake in Xylem Inc. by 7.1% during the second quarter, selling 10,626 shares and retaining 138,655 shares valued at approximately $17.94 million. Xylem (NYSE: XYL) maintains a "Moderate Buy" consensus rating from analysts with an average target price of $167.40, following strong Q3 earnings where the company beat EPS and revenue estimates and declared a $0.40 quarterly dividend. Insider transactions also showed sales by EVP Claudia S. Toussaint and Director Victoria D. Harker in late October and early November.

**2. Xylem (NYSE: XYL) EVP reports 1,840-share tax withholding event**
- Source: Stock Titan | 20251215T210847 | Neutral | Relevance: 98%
- Rodney Aulick, EVP and President of WSS at Xylem Inc. (NYSE: XYL), reported a tax-related share withholding on December 15, 2025. This involved 1,840 shares of Xylem common stock, valued at $138.25 per share, withheld to cover tax liabilities from the vesting of restricted stock units. After this transaction, Aulick directly owns 72,826 shares of Xylem common stock.

**3. Will a New CFO With M&A Roots Reshape IDEX's (IEX) Capital Allocation Narrative?**
- Source: Simply Wall Street | 20251214T014200 | Neutral | Relevance: 61%
- IDEX Corporation has appointed Sean M. Gillen as their new CFO, effective January 5, 2026. Gillen's background in capital markets and M&A experience is expected to influence future capital allocation decisions, potentially reshaping IDEX's investment narrative. The company continues its dividend approval and cost-saving initiatives despite challenges from tariffs and softer demand in some sectors.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-05 | TD Cowen | $135 | $130 | +4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-05 | TD Cowen | main | Hold |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 4 ($2.57M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.7% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 12.3% (+0.7%)
- Blackrock Inc.: 10.2% (+1.6%)
- State Street Corpora: 4.5% (+1.2%)
- Geode Capital Manage: 2.5% (+1.1%)
- Impax Asset Manageme: 2.2% (-3.3%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.14 elevated, pricing in significant growth expectations. Forward P/E 24.7x stretched relative to 10% growth. Insider selling cluster ($2.6M in 90 days), potential headwind. Institutional flow bearish (5 selling vs 5 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $33.5B |
| Beta | 1.17 |
| 52W Range | $100.47 - $154.27 |
| Short Interest | 1.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.14 |
| Forward P/E | 24.7 |
| Current P/E | 27.2 |
| YoY Growth | 9.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -4.0% to -1.2% (+2.8% in 5 days), confirming momentum buildup. Below STRENGTH zone by 5.2pp (needs >4.0% for momentum thesis). MRS_5 turning positive (0.4%) - potential reversal signal. Underperforming sector by 3.1pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.03x) but short-term weakness (below SMA20). OFD pattern: -STL (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.18% (CS: 31) | Neutral |
| RSI_14 | 39.3 | Neutral |
| MACD Histogram | 0.01 | Bullish |
| vs SMA20 | 0.987x | Below |
| vs SMA50 | 0.952x | Below |
| vs SMA200 | 1.032x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $137.59
- **Stop Loss:** $132.59 (3.6% risk)
- **Target:** $142.59 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 240
- **Position Value:** $33,021.60
- **Portfolio %:** 33.02%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with balanced risk positioning. VIX remains calm at 16.48 while breadth shows modest improvement to 52%, indicating neither euphoria nor distress. Mixed sectoral themes from energy weakness to AI expansion suggest stock-picking environment rather than broad directional moves.*

### Earnings

**Next:** 2026-02-03 (Est: $1.41)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.23 | $1.37 | +11.1% |
| 2025Q2 | $1.15 | $1.26 | +9.9% |
| 2025Q1 | $0.95 | $1.03 | +8.0% |
| 2024Q4 | $1.13 | $1.18 | +4.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*